17 Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood ,2000;95(2):543-550

18 Simard B, Gabra BH, Sirois P. Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can J Physiol Pharmacol ,2002;80(12):1203-1207

19 Sugi T, Makino T. Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy. J Reprod Immunol ,2000;47(2):169-184

20 Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res ,1998;83(12):1182-1191

21 Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, Matsuura H, Chayama K, Teranishi Y, Iba O, Amano K, Matsubara H. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension ,2003;41(1):99-107

22朱僖星,主编.现代糖尿病学.上海:上海医科大学出版社,2000:300-305

23许曼音,主编.糖尿病学.上海:上海科学技术出版社,2004:189-215

24朱鸿,施彩虹.糖尿病视网膜病变的相关诊断技术展望.国际眼科杂志,2005;5(5):1016-1019

25李媛,卢艳.糖尿病视网膜病变早期发病机制研究进展.国际眼科杂志,2005;5(4):750-754

26孙文涛,张小玲,高嵩.糖尿病性视网膜病变发生发展的相关因素.国际眼科杂志,2005;5(4):755-759

27张小玲,邱曙东,陈艳炯,孙文涛.糖尿病性视网膜病变发病机制研究进展.国际眼科杂志,2005;5(6):1239-1241

28 Nathan DM. The Pathophysiology of Diabetic Complications: How Much Does the Glucose Hypothesis Explain?Ann Inter Med ,1996;124(1pt2):86-89

29 Igic R. Kallikrein and kininases in ocular tissues. Exp Eye Res ,1985;41(1):117-120

30 Zuccollo A, Navarro M, Catanzaro O. Effects of B1 and B2 kinin receptor antagonists in diabetic mice. Can J Physiol Pharmacol ,1996;74(5):586-589

31 Christopher J, Jaffa AA. Diabetes modulates the expression of glomerular kinin receptors. Int Immunopharmacol ,2002;2(13-14):1771-1779

32 Koch M, Wendorf M, Dendorfer A, Wolfrum S, Schulze K, Spillmann F, Schultheiss HP, Tschope C. Cardiac kinin level in experimental diabetes mellitus: role of kininases. Am J Physiol Heart Circ Physiol ,2003;285(1):418-423

33 Hatcher HC, Ma JX, Chao J, Chao L, Ottlecz A. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci ,1997;38(3):658-664

34 Ma JX, King LP, Yang Z, Crouch RK, Chao L, Chao J. Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy. Curr Eye Res ,1996;15(11):1117-1123

上一页  [1] [2] [3] [4] [5] [6]